Except for 0.1 μmol/L ADP and 0.1 mg/mL ristocetin, all tested concentrations of activators significantly increased adhesion of both control and T2D platelets to albumin (p < 0.0001, Fig. 2a). This evidence concerns the gene ALB and type 2 diabetes mellitus.